Accrued Expenses

9 Months Ended

Sep. 30, 2024

Accrued Expenses [Abstract]

Accrued Expenses

(5) Accrued Expenses

Accrued expenses consisted of the following:

	September 30,		December 31,
	2024		2023
Accrued interest	$	352,775		—
Clinical trial costs		350,208		276,141
Incentive and other compensation costs		297,897		1,082,606
Director fees		70,000		60,210
Franchise taxes		3,150		12,160
Other		53,615		13,179
Accrued expenses	$	1,127,645		1,444,296